ArticleNeoplasia (New York, N.Y.)2008

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Charles N Landen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.